NCT00568347View on ClinicalTrials.gov

Evaluation Inhaled Corticosteroids on Exhaled Nitric Oxide Gas Exchange

CompletedOBSERVATIONAL
Enrollment

39

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

October 31, 2013

Study Completion Date

October 31, 2013

Conditions
COPD
Interventions
DRUG

fluticasone 100mcg/ salmeterol 50mcg

inhaled fluticasone 100mcg/salmeterol 50mcg bid X 3 months

DRUG

fluticasone 250/salmeterol 50

inhaled fluticasone 250/salmeterol 50 X 3 months to evaluate effect on lung function and exhaled nitric oxide

DRUG

salmeterol

salmeterol 50 mcg by dry powder inhaler disk bid to evaluated effect on lung function and exhaled nitric oxide

DRUG

Salmeterol

salmeterol 50mcg bid X 3months

DRUG

salmeterol and fluticasone propionate

salmeterol 50mcg/fluticasone 250mcg by DPI bid

Trial Locations (1)

90712

Arthur F Gelb MD, Lakewood

All Listed Sponsors
lead

Arthur F Gelb MD

INDIV

NCT00568347 - Evaluation Inhaled Corticosteroids on Exhaled Nitric Oxide Gas Exchange | Biotech Hunter | Biotech Hunter